Dr. Susan Band Horwitz Wins ‘Canada’s Nobel’

Dr. Susan Band Horwitz Wins ‘Canada’s Nobel’

In April Susan Band Horwitz, Ph.D., distinguished professor and former co-chair of molecular pharmacology and the Rose C. Falkenstein Chair in Cancer Research, received the 2019 Canada Gairdner International Award. Nicknamed “Canada’s Nobel,” the annual prize recognizes outstanding biomedical scientists who have made original contributions to medicine.

Groundbreaking research by Dr. Horwitz on the mechanism of action of the chemotherapy drug Taxol paved the way for it to become a blockbuster medication that is used to treat ovarian, breast, and lung cancers.

Dr. Horwitz has received numerous honors and awards, including the C. Chester Stock Award from Memorial Sloan Kettering Cancer Center, the Warren Alpert Foundation Prize from Harvard Medical School, The Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research, The American Cancer Society’s Medal of Honor, and the American Association of Cancer Research’s (AACR) Lifetime Achievement Award.

She has served as president of the AACR and is a member of the National Academy of Sciences and many other organizations and societies.

More From Einstein

Preparing New Grads for Hospital Roles
Einstein Celebrates 65th Commencement
Class of 2027 Receives White Coats
Mentoring in Medicine Paves Way for Success
Biomedical Sciences Leadership Program Begins
Einstein, Lehman Launch M.S. Program
2023 National Diversity Award
Health Equity Scholarship Honors Nilda Soto
Longevity Gene Project Awarded $13.6M

Content

Highlights
Features
Campus News
Research Notes
Motivations: Donors & Alumni
More From This Issue

Past Issues

Download Magazine

Search

Subscribe